Urolog. pro Praxi, 2009; 10(5): 264-268

Hormone replacement therapy of aging men

prof. MUDr. RNDr. Luboslav Stárka DrSc
Endokrinologický ústav, Praha

The aim of the study was to review actual problems and recent findings in diagnosis and treatment of male late-onset hypogonadism

and guidelines, which appeared recently. Conclusions of present guidelines for testosterone treatment of hypogonadism of aging males

and the joint statements of the International society of study of aging male ISSAM, International society of andrology ISA, and European

association for Urology EAU for investigation, diagnosis, treatment and monitoring of male late-onset hypogonadism.

Keywords: testosterone, substitution therapy, prostate, side effects.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stárka L. Hormone replacement therapy of aging men. Urol. praxi. 2009;10(5):264-268.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Travison TG, Araujo AB, O'Donnell AB, Kupelian V, McKinlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2007; 92(1): 196-202. Go to original source... Go to PubMed...
    2. Andersson AM, Jensen TK, Juul A, Petersen JH, J?rgensen T, Skakkebaek NE. Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J Clin Endocrinol Metab. 2007; 92(12): 4696-4705. Go to original source... Go to PubMed...
    3. Stárka L. Aktuality v andrologické endokrinologii. Urol. Listy 2008; 6(4): 54-58.
    4. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male. 2002; 5(2): 74-86. Go to original source... Go to PubMed...
    5. Kubíček V. Racionální substituční terapie androgeny pro muže. Andrologie 2000; 1: 2-10.
    6. Kubíček V. Stárnoucí muž. Lék Listy 2003; 38: 15-18. Go to original source...
    7. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur. J. Endocrinol. 2008; 159(5): 507-514, Int J Impot Res. 2009; 21(1): 1-8, Int J Androl. 2009; 32(1): 1-10, Int J Androl. 2009; 32(1): 1-10, Aging Male. 2008: 1-8. Go to original source... Go to PubMed...
    8. Hanuš M, Matoušková M, Stárka L, Hill M. Hormonal homeostasis in a group of 216 aging Czech males and correlation with responses to a questionnaire of the University of St. Louis, Aging Male. 2006; 9(2): 103-110. Go to original source... Go to PubMed...
    9. Vermeulen A. Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays. J Endocrinol Invest. 2005; 28(3 Suppl): 28-31.
    10. Mohr BA, Guay AT, O´Donnell AB, McKinlay JB. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf). 2005; 62(1): 64-73. Go to original source... Go to PubMed...
    11. Zámečník L. Erektilní dysfunkce. Postgrad Med. 2008; 10: 383-390.
    12. Carpenter WR, RobinsonWR, Godley PA. Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer. J Nat Cancer Inst. 2008; 100: 158-159. Další literaturu k jednotlivým uvedeným otázkám je možno nalézt zejména v článcích uvedených sub 5. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.